BOEHRINGER-INGELHEIM
2.6.2022 15:12:08 CEST | Business Wire | Press release
Boehringer Ingelheim and the Agency for Science, Technology and Research (A*STAR) today announced a global licensing agreement under which Boehringer Ingelheim will obtain exclusive worldwide rights to research, develop and commercialize products based on a panel of innovative, tumor-specific antibodies from A*STAR. Boehringer Ingelheim aims to use these antibodies to direct therapeutic effector mechanisms such as antibody-drug conjugates (ADCs) and T-cell engagers exclusively to tumor cells, and to that end develop a range of highly targeted cancer treatments.
“Boehringer Ingelheim believes that these promising antibodies in-licensed from A*STAR will help us advance potent therapeutic candidates against key molecular cancer targets,” says Clive R. Wood, Senior Corporate Vice President and Global Head of Discovery Research at Boehringer Ingelheim and continues: “We look forward to developing these assets for a broad range of cancers with the goal to deliver breakthrough opportunities for patients.”
Boehringer Ingelheim is pioneering a range of versatile therapeutic platforms in order to develop innovative medicines that target the tumor directly (tumor cell-directed therapies) or that enable the immune system to target the tumor (immune cell-targeted therapies). One tumor cell-directed modality is antibody drug conjugates, which allows for delivery of toxins directly into tumor cells. Another is T-cell engagers facilitating direct contact between T-cells and tumor cells, leading to T-cell-mediated killing of the tumor. Both technologies are directed towards markers on the surface of cancer cells, also known as antigens, in order to attack tumor cells but spare healthy tissues.
The innovative antibodies from A*STAR can potentially enable the development of safer, more efficacious therapies as they selectively bind to antigens that are highly expressed on tumor cells but are absent on normal healthy tissues.
Under the terms of the agreement, Boehringer Ingelheim will be responsible for further research, preclinical and clinical development as well as commercialization of targeted cancer therapies using the antibodies from A*STAR. A*STAR may receive payments totalling >100 million EUR in upfront and success-based development and commercialization milestones.
The technology used to identify the unique A*STAR antibodies resulted from a multi-institutional collaboration in Singapore. A*STAR’s Genome Institute of Singapore (GIS) and Institute of Bioengineering & Bioimaging (IBB) generated antibodies which exclusively target antigens that were initially identified from gastric cancer cells. Experimental Drug Development Centre (EDDC), Singapore’s national platform for drug discovery and development hosted by A*STAR, then optimized the antibodies and confirmed their applicability to a range of other solid cancers. EDDC also demonstrated the utility of these antibodies in directing different therapeutic modalities selectively to cancer cells.
Professor Damian O'Connell, Chief Executive Officer of EDDC, says, “As Singapore's national drug discovery and development platform, EDDC is proud to translate great science in Singapore into valuable assets that can enable the precise treatment of cancer. We believe that Boehringer Ingelheim, with its broad expertise and technologies, is the right partner to maximize the potential of these antibodies for the development of safer, more targeted therapies for cancer patients.”
Professor Tan Sze Wee, Assistant Chief Executive (Enterprise) of A*STAR, says, “These antibodies were developed in Singapore through close collaboration across multiple institutions. There was also strong support by the Singapore Gastric Cancer Consortium. The agreement is testament to the best-in-class research taking place in Singapore. Cancer is a devastating disease, and we hope the fruits of our research can improve patient outcomes.”
Please click on the link for “Note to Editors’ and ‘References’:
View source version on businesswire.com: https://www.businesswire.com/news/home/20220602005475/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Audiencerate: Riccardo Fabbri Joins as Chief Technology Officer—The AI-Driven Phase of the Platforms for SMEs and Media Agencies Begins21.5.2026 09:00:00 CEST | Press release
The co-founder and former managing partner of Nohup (acquired by Havas Group in 2021) will lead the development of the artificial intelligence infrastructure that integrates first-party and third-party data, powering the platform delivered with Postel and Microsoft to Italian SMEs and the platform with the DV360 offering for global media agencies. Audiencerate Ltd, one of the few globally certified Google Customer Match Upload Partners and a Microsoft IP Co-sell certified partner with MACC eligibility, today announced the appointment of Riccardo Fabbri as Chief Technology Officer. The appointment marks a phase of dual expansion: the Audiencerate–Postel–Microsoft platform for Italian SMEs, and the Data platform integrated with Google DV360 for Agencies and Data Providers — both evolving toward a model that natively leverages first-party and third-party data through AI and machine learning. This press release features multimedia. View the full release here: https://www.businesswire.com/n
Phison's Pascari Enterprise Storage Honored with COMPUTEX Best Choice Golden Award for Breakthrough 245.76 TB Capacity21.5.2026 08:30:00 CEST | Press release
Latest PCIe Gen5 SSD lowers costs at scale for optimized data center OPEX Phison Electronics (8299TT), a global leader in NAND flash controllers and storage solutions, today announced that its Pascari D206V PCIe Gen5 data center SSD has received the prestigious COMPUTEX Best Choice Golden Award, recognizing the next generation of innovation in ultra-high-capacity enterprise storage for AI and modern data center infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260520865786/en/ Pascari D206V Wins COMPUTEX Best Choice Golden Award in 2026 The Pascari D206V is designed to address the growing industry challenge of efficiently scaling storage capacity for AI, cloud and data-intensive workloads without increasing operational complexity or infrastructure costs. Delivering up to 245.76 TB in a single U.2 PCIe Gen5 SSD, the D206V enables hyperscale and enterprise customers to significantly increase storage density while
Truecaller Travel eSIM Launch Powered by Telness Tech’s Seamless OS21.5.2026 08:30:00 CEST | Press release
Telness Tech, the telecom software company behind Seamless OS, today announced that Truecaller’s newly launched Travel eSIM service is powered by its platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260520906699/en/ Telness Tech, the telecom software company behind Seamless OS, today announced that Truecaller’s newly launched Travel eSIM service is powered by its platform. Truecaller, the leading global platform for verifying contacts and blocking unwanted communication, has launched Travel eSIM across 29 countries, marking the company’s move into mobile data services. The launch broadens Truecaller’s platform beyond caller ID and spam protection, and for the first time adds digital consumables to the portfolio. With more than 500 million people already using Truecaller in their daily communication, Travel eSIM extends that relationship to international travel — a category where users routinely overpay for connectivi
AHS Properties: At 26, Abbas Sajwani Is Deploying Billions Into Dubai’s Future21.5.2026 08:00:00 CEST | Press release
Named the youngest billionaire in real estate globally by Forbes, the AHS Properties founder is scaling a AED 50 billion pipeline on a single conviction: Dubai is no longer a luxury market - it’s a capital destination. While global real estate capital recalibrates, Abbas Sajwani is accelerating. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260519804834/en/ Abbas Sajwani, Founder and CEO of AHS Properties. (Photo: AETOSWire) The 26-year-old Founder and CEO of AHS Properties - recently recognised by Forbes as the youngest Arab billionaire and the youngest billionaire globally in real estate, with a net worth of $1.9 billion - is building one of the fastest-scaling development platforms in Dubai. Since launching in 2021, AHS Properties has expanded from ultra-luxury villa redevelopments into a multi-billion-dollar portfolio spanning waterfront residential, Grade-A commercial, and large-scale mixed-use developments across Duba
Xsolla and the Dubai Films and Games Commission Create a Strategic Partnership to Connect Dubai-Based Developers to Global Markets21.5.2026 05:16:00 CEST | Press release
Multi-Year Agreement Creates Opportunities to Build All The Things for Video Games in Dubai and MENA Xsolla, a leading global video game commerce company, and the Dubai Games Commissioner, in coordination with the Dubai Films and Games Commission, announced a multi-year strategic partnership to accelerate the development of the video game industry and expand commercial access for developers operating across the Middle East and North Africa. The announcement was made at GamesBeat Summit 2026 in Los Angeles, California. The partnership will unite Xsolla's global commerce infrastructure, including direct-to-consumer storefronts, intelligent payments across 1,000+ payment methods in 200+ geographies, and player engagement tools, with DFGC's mandate to establish Dubai as a world-class destination for video game development and publishing. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260520329315/en/ Xsolla and the DFGC partner
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom